Skip to main content

Johnson & Johnson pauses coronavirus vaccine trials after unexplained illness

The drug maker announced Monday night that the 60,000-patient, late-stage trials have been put on hold and new enrollment has been halted, citing “an unexplained illness in a study participant.”
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.